Xing-Li Fu
Overview
Explore the profile of Xing-Li Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang G, Fu X, Wang J, Guan R, Sun Y, To S
J Cell Physiol
. 2018 Jan;
234(5):5888-5903.
PMID: 29336479
Glioblastoma multiforme (GBM) is the most malignant and aggressive glioma with abnormal expression of genes that mediate glycolytic metabolism and tumor cell growth. Petunidin-3-O-glucoside (Pt3glc) is a kind of anthocyanin...
12.
Jiang Z, Peng J, Yang H, Fu X, Wang J, Liu L, et al.
Exp Mol Med
. 2017 May;
49(5):e329.
PMID: 28496199
Osteosarcoma is suggested to be caused by genetic and molecular alterations that disrupt osteoblast differentiation. Recent studies have reported that transmembrane protein 119 (TMEM119) contributes to osteoblast differentiation and bone...
13.
Fu X, Fang Z, Shu L, Tao G, Wang J, Rui Z, et al.
Oncotarget
. 2017 Apr;
8(21):34340-34351.
PMID: 28423720
A meta-analysis was conducted to compare oxaliplatin-based with fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. MEDLINE, EMBASE and CENTRAL were systematically searched for relevant randomized controlled...
14.
Wang G, Wang J, Guan R, Du L, Gao J, Fu X
Nutr Cancer
. 2017 Mar;
69(4):534-554.
PMID: 28323500
The imbalance between glucose metabolism and cancer cell growth in tumor microenvironment (TME), which are closely related with the occurrence and progression of cancer. Accumulating evidence has demonstrated that flavonoids...
15.
Wang G, Wang J, Fu X, Guang R, To S
Oncol Rep
. 2016 Dec;
37(2):657-670.
PMID: 27959421
Cell metabolism can be reprogrammed by tissue hypoxia leading to cell transformation and glioblastoma multiforme (GBM) progression. In response to hypoxia, GBM cells are able to express a transcription factor...
16.
Ruan Z, Fu X, Li W, Ye J, Wang R, Zhu L
Biomed Pharmacother
. 2016 Oct;
84:666-673.
PMID: 27697639
Background: Notch and NF-κB signaling pathways both play important roles in the regulation of atherosclerosis (AS). However, the mechanisms of notch and NF-κB signaling pathways on AS are still unclear....
17.
Wu G, Cai B, Yu F, Fang Z, Fu X, Zhou H, et al.
Oncotarget
. 2016 Sep;
7(52):87511-87522.
PMID: 27626180
Background: To compare short-term and long-term results of bariatric surgery vs non-surgical treatment for type 2 diabetes mellitus (T2DM). Methods: A systematic search was conducted in the PubMed, Embase, and...
18.
Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma
Wang G, Fu X, Wang J, Guan R, Tang X
Curr Cancer Drug Targets
. 2016 Aug;
17(1):17-39.
PMID: 27562399
Glioblastoma multiforme is a common primary brain tumor, which exhibits an imbalance between glioma cell growth and glucose metabolism. Recent discoveries have found that the multiple pathways and downstream genes...
19.
Zhou H, Su X, Fu X, Wu G, Luo K, Fang Z, et al.
Oncotarget
. 2016 May;
7(27):41294-41305.
PMID: 27191496
Mesenchymal stem cells (MSCs) could be ideal delivery vehicles for antitumor biological agents in pancreatic adenocarcinoma (PA). While the role of MSCs in tumor growth is elusive. Inflammation is an...
20.
Lin Y, Wang Y, Fu X, Li W, Wang Y, Ma J
Oncotarget
. 2016 Apr;
7(19):28384-92.
PMID: 27070091
Bladder cancer is a heterogeneous disease with outcome difficult to predict, and novel predictive biomarkers are needed. PCDH7, a member of protocadherins family, functions as tumor suppressor in several human...